Osaic Holdings’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History
Bought
Maintained
Sold
Other funds holding QNTM
Osaic Holdings's QNTM Position: Q3 2026 in Review
Osaic Holdings increased its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) stake by 5.1% in Q3 2026, buying an estimated $1.07K and bringing the position to 6,617 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6056.
Osaic Holdings first reported a position in QNTM in Q2 2021 and has held it in 21 quarters since. The position peaked at $38.5K in Q4 2025. 28 funds tracked by Wall St. Rank hold QNTM as of Q3 2026.
- Osaic Holdings held 6,617 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $23.8K as of Q3 2026.
- Osaic Holdings bought 322 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2026, an estimated $1.07K.
- Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6056 holding.
- Osaic Holdings first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2021 and has held it in 21 quarters since.
- Osaic Holdings's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $38.5K in Q4 2025.
- 28 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.